Dr. Crary is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
630 W 168th St
Ph 1564W
New York, NY 10032Phone+1 212-305-7399
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Neuropathology, 2008 - 2010
- New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 2006 - 2008
- SUNY Downstate Medical CenterPh.D., Neural & behavioral science, 1997 - 2006
- State University of New York Downstate Medical Center College of MedicineClass of 2006
- Brown UniversitySc.B., Neuroscience, with Honors, 1992 - 1996
Certifications & Licensure
- NY State Medical License 2008 - 2025
- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Neuropathology
Awards, Honors, & Recognition
- Alexander Saint-Amand Scholar 2016
- Louis V. Gerstner, Jr. Scholar 2011
- SUNY Chancellor’s Award for Student Excellence 2006
- Join now to see all
Publications & Presentations
PubMed
- 49 citationsRainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy.Shanu F Roemer, Lea T Grinberg, John F Crary, William W Seeley, Ann C McKee
Acta Neuropathologica. 2022-10-01 - 134 citationsPART, a distinct tauopathy, different from classical sporadic Alzheimer diseaseKurt A. Jellinger, Irina Alafuzoff, Johannes Attems, Thomas G. Beach, Nigel J. Cairns
Acta Neuropathologica. 2015-03-17 - 990 citationsPrimary age-related tauopathy (PART): a common pathology associated with human agingJohn F. Crary, John Q. Trojanowski, Julie A. Schneider, Jose F. Abisambra, Erin L. Abner
Acta Neuropathologica. 2014-10-28
Lectures
- Tautologies & TauUniversity of California San Diego - 1/1/2017
- Age-related tauopathy: Clinical, genetic and molecular studies.1/1/2017
- Refining the neuropathological criteria for Alzheimer's diseaseNew York, NY - 1/1/2016
- Join now to see all
Press Mentions
- Mount Sinai Researchers Use Artificial Intelligence to Uncover the Cellular Origins of Alzheimer’s Disease and Other Cognitive DisordersSeptember 20th, 2022
- AI Platform Shows Potential in Diagnosing Patients at Early StagesApril 28th, 2022
- PreciseDx’s AI-Enabled Digital Pathology Proven to Detect Early-Stage Parkinson’s DiseaseApril 20th, 2022
- Join now to see all
Grant Support
- : Regulation of tau expression in Alzheimer disease and agingNIH/NIA2016–2021
- Mechanisms of age-related tauopathyNIH/NIA2015–2020
- Clinical-Pathological Study of Cognitive Impairment in ETNIH/NINDS2014–2019
- Molecular & genetic investigation of tau in CTEDepartment of Defense2014–2019
- Aptamer-based bioactuators for early diagnosis of ADSaint-Amand Research Scholar Award2016–2017
- Career Development in the Neuropathology of ADNIH/NIA2015–2017
- Regulation of tau expression and toxicity by miR-219Rainwater Foundation2015–2017
- Neuropathological characterization of PARTAlzheimer's Association2015–2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: